NCT00542178 Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) Status COMPLETED Phase PHASE3
NCT00524875 Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients Status UNKNOWN Phase NA
NCT00511875 Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT00505947 Treatment of Refractory Diabetic Macular Edema With Infliximab Status TERMINATED Phase PHASE3
NCT00500097 Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training Status COMPLETED Phase NA
NCT00498147 Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program Status UNKNOWN Phase N/A
NCT00496405 Unilateral Bevacizumab for Bilateral Diabetic Macular Edema Status WITHDRAWN Phase PHASE4
NCT00476918 Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema Status UNKNOWN Phase PHASE1
NCT00457470 A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) Status WITHDRAWN Phase PHASE2
NCT00443521 Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE2/PHASE3
NCT00423059 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy Status COMPLETED Phase NA
NCT00414999 A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00411333 Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy Status COMPLETED Phase EARLY_PHASE1
NCT00407849 Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema Status UNKNOWN Phase PHASE1/PHASE2
NCT00407108 Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy Status WITHDRAWN Phase PHASE3
NCT00403195 Clinical and Pathophysiological Description of Ocular Ischemic Syndrome Status COMPLETED Phase N/A